Earnings Summary: Neurocrine Biosciences Q4

Neurocrine Biosciences NBIX just disclosed its Q4 earnings on Thursday, February 6, 2025 at 04:01 PM.

Here's a brief overview of the earnings report.

Earnings

Neurocrine Biosciences missed estimated earnings by -1.0%, reporting an EPS of $1.69 versus an estimate of $1.71.

Revenue was up $112.50 million from the same period last year.

Overview of Past Earnings

During the previous quarter, the company beat on EPS by $0.3, leading to a 3.0% drop share price change the next day.

Here's a look at Neurocrine Biosciences's past performance:

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.